Related Experiment Video
Updated: Mar 29, 2026
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
Mitomycin-C suppresses mucus secretion in an ileal neobladder rat model
Weiwei Fan1, Yang Yu2, Junjie Shu1
1Dalian Medical University, Dalian, Liaoning 116085, P.R. China.
Abstract:
The aim of the present study was to investigate the mucus secretion status of mature goblet cells following the application of mitomycin-C (MMC) in ileal neobladder rat models. Bladder substitution models were established in Sprague Dawley rats, which had been divided into five groups, namely the control (sham), normal saline (NS), high-dose MMC (HMMC), low-dose MMC (LMMC) and dehydrated alcohol (DA) groups. To evaluate the total protein concentration and level of sialic acid following the therapy, urine from the rats in each group was collected on days 8, 11 and 14. In addition, to observe the variances between mucus secretion and the ileum goblet cells, immunohistochemistry and hematoxylin and eosin staining were conducted in the different groups on day 17. The results indicated that the ileal neobladder mucosas in the MMC groups were clearly undamaged, as compared with the DA group. Furthermore, the MMC and DA groups were shown to inhibit the proliferation of goblet cells. The concentration of protein and sialic acid in the LMMC group was found to be lower compared with the NS group, while the concentration in the HMMC group was considerably lower. In conclusion, HMMC was demonstrated to evidently reduce the mucin and sialic acid concentration in the urine, without visible damage to the ileal neobladder mucus membrane. Therefore, MMC may provide a novel therapeutic approach for the treatment of certain bladder conditions.
Insights
Mitomycin-C (MMC) reduced urine mucin and sialic acid in ileal neobladder models without damaging the mucus membrane. This suggests MMC may offer a new treatment for bladder conditions.
Area of Science:
- Urology
- Gastroenterology
- Biomedical Engineering
Background:
- Ileal neobladders are used for bladder substitution.
- Goblet cells secrete mucus, crucial for mucosal protection.
- Mitomycin-C (MMC) is used in some urological treatments.
Purpose of the Study:
- To investigate the effect of Mitomycin-C (MMC) on mucus secretion in goblet cells of ileal neobladder rat models.
- To evaluate protein and sialic acid levels in urine after MMC application.
- To assess the impact of MMC on ileal goblet cell morphology and mucus production.
Main Methods:
- Establishment of ileal neobladder rat models in Sprague Dawley rats.
- Division into five groups: control, normal saline, high-dose MMC, low-dose MMC, and dehydrated alcohol.
- Urine collection for protein and sialic acid analysis on days 8, 11, and 14.
- Immunohistochemistry and H&E staining on day 17 to evaluate goblet cells and mucus secretion.
Main Results:
- Ileal neobladder mucosa remained undamaged in MMC groups compared to the dehydrated alcohol group.
- Both MMC and dehydrated alcohol inhibited goblet cell proliferation.
- Protein and sialic acid concentrations were lower in low-dose MMC and significantly lower in high-dose MMC groups compared to normal saline.
Conclusions:
- High-dose Mitomycin-C (HMMC) effectively reduced urinary mucin and sialic acid.
- HMMC did not cause visible damage to the ileal neobladder mucus membrane.
- MMC presents a potential novel therapeutic strategy for specific bladder conditions.
